Squarepoint’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-59,285
Closed -$220K 4760
2025
Q4
$220K Sell
59,285
-35,681
-38% -$306K ﹤0.01% 3804
2025
Q3
$1.34M Buy
94,966
+57,719
+155% +$900K ﹤0.01% 2427
2025
Q2
$716K Buy
37,247
+16,255
+77% +$254K ﹤0.01% 2950
2025
Q1
$232K Buy
20,992
+10,540
+101% +$126K ﹤0.01% 3916
2024
Q4
$174K Buy
+10,452
New +$130K ﹤0.01% 4521
2024
Q3
Sell
-5,353
Closed -$309K 4533
2024
Q2
$309K Buy
5,353
+2,279
+74% +$112K ﹤0.01% 3410
2024
Q1
$102K Sell
3,074
-5,577
-64% -$282K ﹤0.01% 3794
2023
Q4
$702K Buy
+8,651
New +$704K ﹤0.01% 2767
2023
Q3
Sell
-746
Closed -$245K 4108
2023
Q2
$245K Buy
+746
New +$228K ﹤0.01% 3094
2022
Q4
Sell
-1,349
Closed -$322K 3498
2022
Q3
$322K Sell
1,349
-2,885
-68% -$773K ﹤0.01% 2444
2022
Q2
$944K Sell
4,234
-277
-6% -$119K 0.01% 1639
2022
Q1
$3.07M Buy
+4,511
New +$2.71M 0.01% 917
2021
Q1
Sell
-333
Closed -$284K 3476
2020
Q4
$284K Sell
333
-32
-9% -$24.7K ﹤0.01% 2247
2020
Q3
$274K Buy
+365
New +$300K ﹤0.01% 1869

Other funds holding OM

Squarepoint's OM Position: Q1 2026 in Review

Squarepoint sold out of Outset Medical (OM) in Q1 2026, closing a stake of 59,285 shares — an estimated $220K sold.

Squarepoint first reported a position in OM in Q3 2020 and held it in 14 quarters. The position peaked at $3.07M in Q1 2022. 99 funds tracked by Wall St. Rank hold OM as of Q1 2026.

  • Squarepoint reported no remaining Outset Medical position as of Q1 2026 after selling out during the quarter.
  • Squarepoint sold 59,285 Outset Medical shares in Q1 2026, an estimated $220K.
  • Squarepoint first reported a position in Outset Medical in Q3 2020 and held it in 14 quarters.
  • Squarepoint's Outset Medical position peaked at $3.07M in Q1 2022.
  • 99 funds tracked by Wall St. Rank held Outset Medical as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.